ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Tankut Hakki Akay
Bahadir Gultekin
Süleyman Ozkan
Atilla Sezgin
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Akay, T. H.
Right arrow Articles by Aslamaci, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Akay, T. H.
Right arrow Articles by Aslamaci, S.
Related Collections
Right arrow Valve disease

Ann Thorac Surg 2006;82:1729-1734
© 2006 The Society of Thoracic Surgeons

Original Articles: Cardiovascular

Triple-Valve Procedures: Impact of Risk Factors on Midterm in a Rheumatic Population

Tankut Hakki Akay, MD*, Bahadir Gultekin, MD, Süleyman Ozkan, MD, Erdal Aslim, MD, Bülent Saritas, MD, Atilla Sezgin, MD, Sait Aslamaci, MD

Department of Cardiovascular Surgery, Baskent University Hospital, Ankara, Turkey

Accepted for publication May 16, 2006.

* Address correspondence to Dr Akay, Çankaya PTT, PK-56 Çankaya Ankara, 06552/Turkey (Email: tankutakay{at}gmail.com).

BACKGROUND: We aimed to determine the influence of preoperative, intraoperative, and postoperative variables on short and midterm results in patients undergoing triple-valve surgery.

METHODS: Between September 1989 and December 2003, 157 patients underwent triple-valve surgery with mechanical prosthetic valves. Preoperative, operative, and postoperative data were retrospectively analyzed and risk factors affecting hospital mortality and short and midterm survival were evaluated.

RESULTS: The hospital mortality was 2.5%. Multivariate analysis revealed that New York Heart Association functional class IV, low left ventricular ejection fraction (< 0.35) and increased left ventricular end diastolic diameter (> 50 mm Hg) were associated with increased short and midterm mortality. The freedom rate from reoperation and thromboembolic complications at 5 years were 93% ± 4% and 81% ± 7%, respectively. In echocardiographic assessments, significant decrease in left ventricular end-diastolic and end-systolic diameters (53.1 ± 8.3 vs 50.1 ± 7.1, p = 0.002 and 35.3 ± 7.4 vs 32.6 ± 7.2, p = 0.002) was observed.

CONCLUSIONS: Triple-valve surgery offers satisfactory short and midterm results and prevents ventricular dilatation. Mortality significantly decreases if surgery is performed before left ventricle functions deteriorate.




This article has been cited by other articles:


Home page
 Eur. J. Cardiothorac. Surg.Home page
Q.-Q. Han, Z.-Y. Xu, B.-R. Zhang, L.-J. Zou, J.-H. Hao, and S.-D. Huang
Primary triple valve surgery for advanced rheumatic heart disease in Mainland China: a single-center experience with 871 clinical cases
Eur. J. Cardiothorac. Surg., May 1, 2007; 31(5): 845 - 850.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 by The Society of Thoracic Surgeons.